Measurement of cholesterol in plasma and other body fluids.
Measurement of cholesterol has become increasingly important with recognition of its predictive association with cardiovascular diseases. Government and professional groups in the United States and other countries have developed consensus guidelines for using cholesterol and the lipoproteins in identifying patients at risk and in managing therapies. Accuracy in the measurements is essential not only for reliable classification of patients, but also in public health/wellness programs and in research. Laboratory experts have developed requisite analytical performance targets and guidelines for measurements. Manufacturers of diagnostic reagents and laboratories can assure accuracy by accessing the Cholesterol Reference Method Laboratory Network, which offers reference methods for total, high-density lipoprotein, and low-density lipoprotein cholesterol. Recommendations for controlling pre-analytical sources of variation and uniform interpretation of patient results facilitate reliable classification of patients. Driven by increasing workloads and the need for increased efficiency in laboratory testing, dramatic improvements have been made in recent years in automating laboratory analyzers, as well as the methods used for lipoprotein analysis. Newer technology allows multiple sequential measurements in the same cuvette, as well as point-of-care measurements, using strip tests and compact analyzers. Efforts continue to develop reliable, minimally invasive tests in body fluids other than serum.
Warnick
G R
GR
Pacific Biometrics Research Foundation, 24415 SE 156 Street, Issaquah, WA 98027, USA. grwarnick@hotmail.com
Remaley
A T
AT
D000704:Analysis of Variance; D001826:Body Fluids / Q000737:chemistry*; D002784:Cholesterol / Q000032:analysis* / Q000097:blood; D019411:Clinical Laboratory Techniques / Q000592:standards; D006801:Humans; D019095:Point-of-Care Systems / Q000592:standards; D012015:Reference Standards
D002784:Cholesterol